BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38523367)

  • 1. Sirolimus experience in adult patients with vascular malformations.
    Akyildiz A; Ismayilov R; Guven DC; Yildirim HC; Tatar OD; Kus F; Chalabiyev E; Turker FA; Dizdar O; Yalcin S; Gullu HI
    Vascular; 2024 Mar; ():17085381241241853. PubMed ID: 38523367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
    Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oral sirolimus for high-flow vascular malformations in real clinical practice.
    Durán-Romero AJ; Hernández-Rodríguez JC; Ortiz-Álvarez J; Domínguez-Cruz JJ; Monserrat-García MT; Conejo-Mir Sánchez J; Bernabeu-Wittel J
    Clin Exp Dermatol; 2022 Jan; 47(1):57-62. PubMed ID: 34240451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Complex Arteriovenous Malformations Using a Novel Combination Therapeutic Algorithm.
    Chelliah MP; Do HM; Zinn Z; Patel V; Jeng M; Khosla RK; Truong MT; Marqueling A; Teng JMC
    JAMA Dermatol; 2018 Nov; 154(11):1316-1319. PubMed ID: 30326494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
    Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
    Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
    Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
    Shoji MK; Shishido S; Freitag SK
    Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Tolerance of Sirolimus (Rapamycin) for Extracranial Arteriovenous Malformations in Children and Adults.
    Gabeff R; Boccara O; Soupre V; Lorette G; Bodemer C; Herbreteau D; Tavernier E; Maruani A
    Acta Derm Venereol; 2019 Nov; 99(12):1105-1109. PubMed ID: 31386166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
    Maruani A; Tavernier E; Boccara O; Mazereeuw-Hautier J; Leducq S; Bessis D; Guibaud L; Vabres P; Carmignac V; Mallet S; Barbarot S; Chiaverini C; Droitcourt C; Bursztejn AC; Lengellé C; Woillard JB; Herbreteau D; Le Touze A; Joly A; Léauté-Labrèze C; Powell J; Bourgoin H; Gissot V; Giraudeau B; Morel B
    JAMA Dermatol; 2021 Nov; 157(11):1289-1298. PubMed ID: 34524406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No Association of Sirolimus with Wound Complications in Children With Vascular Anomalies.
    Mehl SC; Whitlock RS; Ortega RM; Creden S; Iacobas I; Maricevich RS; Rosenberg TL; Rialon KL
    J Pediatr Surg; 2023 Aug; 58(8):1555-1559. PubMed ID: 36599792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
    Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
    Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
    Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A narrative review of the role of sirolimus in the treatment of congenital vascular malformations.
    Geeurickx M; Labarque V
    J Vasc Surg Venous Lymphat Disord; 2021 Sep; 9(5):1321-1333. PubMed ID: 33737259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Center Experience of Sirolimus Therapy in Head and Neck Low-flow Vascular Malformations.
    Pang C; Evans N; Jethwa P; Papadopoulou A; Khalifa M; Tsui J; Hamilton G; Lim CS; Brookes J
    Vasc Endovascular Surg; 2021 Jul; 55(5):482-490. PubMed ID: 33878964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Our experience with sirolimus for the treatment of complicated vascular anomalies].
    Giménez-Aleixandre C; Méndez-Aguirre NA; Martínez-Menchón T; Girón Vallejo Ó; Fernández-Ibieta M; Ferri-Ñíguez B; Villamil V; Sánchez-Sánchez Á; Montoya-Rangel CA; Hernández-Bermejo JP
    Cir Pediatr; 2019 Jan; 32(1):28-33. PubMed ID: 30714698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).
    Ozeki M; Asada R; Saito AM; Hashimoto H; Fujimura T; Kuroda T; Ueno S; Watanabe S; Nosaka S; Miyasaka M; Umezawa A; Matsuoka K; Maekawa T; Yamada Y; Fujino A; Hirakawa S; Furukawa T; Tajiri T; Kinoshita Y; Souzaki R; Fukao T
    Regen Ther; 2019 Jun; 10():84-91. PubMed ID: 30705924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
    Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
    Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review.
    Saibene AM; Rosso C; Felisati G; Pignataro L; Schindler A; Ghilardi G; Colletti G; Gaffuri M; Mozzanica F
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3529-3540. PubMed ID: 37115326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification of the efficacy of topical sirolimus gel for systemic rare vascular malformations: a pilot study.
    Wataya-Kaneda M; Maeda S; Nakamura A; Hayashi M; Fujimoto M
    J Dermatol; 2023 Dec; 50(12):1619-1624. PubMed ID: 37649426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.